000 01801 a2200469 4500
005 20250513195848.0
264 0 _c19991222
008 199912s 0 0 eng d
022 _a0923-7534
024 7 _a10.1023/a:1008372529239
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCripps, C
245 0 0 _aPhase II study of first-line LY231514 (multi-targeted antifolate) in patients with locally advanced or metastatic colorectal cancer: an NCIC Clinical Trials Group study.
_h[electronic resource]
260 _bAnnals of oncology : official journal of the European Society for Medical Oncology
_cOct 1999
300 _a1175-9 p.
_bdigital
500 _aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdenocarcinoma
_xdrug therapy
650 0 4 _aAged
650 0 4 _aAntineoplastic Agents
_xadministration & dosage
650 0 4 _aColorectal Neoplasms
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aGlutamates
_xadministration & dosage
650 0 4 _aGuanine
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Recurrence, Local
_xdrug therapy
650 0 4 _aPalliative Care
650 0 4 _aPemetrexed
650 0 4 _aSurvival Analysis
650 0 4 _aThymidylate Synthase
_xantagonists & inhibitors
700 1 _aBurnell, M
700 1 _aJolivet, J
700 1 _aBatist, G
700 1 _aLofters, W
700 1 _aDancey, J
700 1 _aIglesias, J
700 1 _aFisher, B
700 1 _aEisenhauer, E A
773 0 _tAnnals of oncology : official journal of the European Society for Medical Oncology
_gvol. 10
_gno. 10
_gp. 1175-9
856 4 0 _uhttps://doi.org/10.1023/a:1008372529239
_zAvailable from publisher's website
999 _c10542506
_d10542506